Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mazdutide 9 mg in Chinese Participants With Obesity
NCT06164873Phase 3Active, not recruiting
- Sponsor
- Innovent Biologics
- Start
- Dec 2023
- Primary completion
- Jun 2025
- Modality
- Hormonal Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of mazdutide in obesity, sponsored by Innovent Biologics. Started Dec 2023; status: active, not recruiting.
02
Drugs
mazdutide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06164873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06164873.